Healthcare is being transformed by aging populations, biologics and cell and gene therapies, digital health, and a shift toward value-based and decentralized care. Our research covers pharmaceuticals and biotechnology, medical devices and equipment, in vitro and molecular diagnostics, healthcare IT, and provider and payer services.
Reports pair market sizing and forecasts with analysis of clinical pipelines, reimbursement and regulation, adoption of new technologies, and the competitive positioning of pharma, device and services companies. The insights support manufacturers, investors and providers in prioritizing therapeutic areas, geographies and product strategy.
No reports found in this category